1. Home
  2. ELUT vs ARAI Comparison

ELUT vs ARAI Comparison

Compare ELUT & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.09

Market Cap

46.5M

Sector

Health Care

ML Signal

HOLD

ARAI

Arrive AI Inc.

HOLD

Current Price

$0.97

Market Cap

38.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELUT
ARAI
Founded
2015
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Diversified Commercial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
46.5M
38.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ELUT
ARAI
Price
$1.09
$0.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$12.00
AVG Volume (30 Days)
189.1K
223.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
10.14
N/A
EPS
N/A
N/A
Revenue
$24,375,000.00
N/A
Revenue This Year
$26.95
N/A
Revenue Next Year
$24.84
$900.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.96
52 Week High
$3.46
$15.50

Technical Indicators

Market Signals
Indicator
ELUT
ARAI
Relative Strength Index (RSI) 50.86 27.49
Support Level $0.86 N/A
Resistance Level $1.39 $3.37
Average True Range (ATR) 0.15 0.09
MACD -0.02 0.05
Stochastic Oscillator 25.00 24.50

Price Performance

Historical Comparison
ELUT
ARAI

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About ARAI Arrive AI Inc.

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: